EOM 1352: Fri 7 June 2024, 11:36
Catalyst 7 July 2023, 14:52
Media Pack
News

Current Edition

Volume 16 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Editorial Archive

Quality-of-life Improvements for Heart Health in Scarce Treatment Settings

When medical circumstances are severe and treatment options are limited in number or effectiveness, being able to help patients improve their quality of life (QOL) t...
19 April 2024 Editorial Archive | Volume 16 Issue 1 circumstances | effectiveness
Continue Reading →
Editorial Archive

Advancing Research and Development of Multi-indication and Combination Therapies for Obesity

Obesity is commonly defined as excess fat accumulation that puts someone at a higher risk for adverse health outcomes.1 The simplicity of this definition can be misl...
19 April 2024 Editorial Archive | Volume 16 Issue 1 accumulation | advancing
Continue Reading →
Volume 15 Issue 2

WhyzeHealth:

Improving Access and Participation in Clinical Trials in Ireland, a Patient-centred Digital Health Platform Across Europe, we continue to see a declining trend in...
6 July 2023 Volume 15 Issue 2 clinical | COVID-19
Continue Reading →
Regional News

Pfizer recalls 2nd blood pressure med in a week, again on potential carcinogen fears

Pfizer issued a second round of Canadian recalls this week as the country’s drug regulator continues to weed out meds with an excess of potential cancer-causing impur...
9 March 2022 Regional News blood | carcinogen
Continue Reading →
Regional News

Teva survey finds COVID has ‘widened the chasm’ on health disparities

By now, it’s no surprise that the global pandemic has worsened long-standing health inequities—and pharma has stepped up with a flood of initiatives to try to tackle ...
2 February 2022 Regional News COVID | health
Continue Reading →
Regional News

Johnson & Johnson CEO: Consumer health split won’t interfere with our ‘more aggressive’ approach to M&A

For anyone playing a drinking game, taking a sip each time the phrase “the new Johnson & Johnson,” was uttered during the company’s fourth-quarter earnings call o...
26 January 2022 Regional News CEO | company
Continue Reading →
Europe

Atlantic Health System enrolling patients in pancreatic cancer clinical trials

Angela Alistar, M.D., director of GI medical oncology at the Carol G. Simon Cancer Center of Morristown Medical Center,...
4 July 2018 Europe atlantic | cancer
Continue Reading →
Europe

CRF Health Industry Luminaries to Share eSource Expertise in Clinical Trials at DIA 2018

CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announced that it will host a series of intera...
13 June 2018 Europe CRF | eSource
Continue Reading →
Europe

Health Citizenship: A New Social Contract To Improve The Clinical Trial Process

Over a quarter of a million clinical trials are currently registered on clinicaltrials.gov. It’s no wonder that society has high hopes for the next cure for cancer, ...
9 May 2018 Europe citizenship | clinical
Continue Reading →
Europe

Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery

New Network Builds on Success of the Company’s Early Phase, Oncology, Psychiatry and Vaccine Catalyst Site Networks  Syneos Health™ (Nasdaq: SYNH), the only fully int...
2 May 2018 Europe catalyst | health
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Pharmap: Wed 13 November 2024, 10:36
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte